EXTRA STRENGTH AFTERTAT (LIDOCAINE HCL) CREAM [RIDGE PROPERTIES]

EXTRA STRENGTH AFTERTAT (LIDOCAINE HCL) CREAM [RIDGE PROPERTIES]
PDF | XML

NDC 69804-003-02, 69804-003-03
Set ID 1ec9a16b-d694-1d4e-e054-00144ff88e88
Category HUMAN OTC DRUG LABEL
Packager Ridge Properties
Generic Name
Product Class Amide Local Anesthetic, Antiarrhythmic
Product Number
Application Number PART348
  • PRINCIPAL DISPLAY PANEL

    principal display panel

  • DOSAGE & ADMINISTRATION

    dosage and administration

  • WARNINGS

    warnings

  • INACTIVE INGREDIENT

    inactive ingredients

  • PURPOSE

    purpose

  • KEEP OUT OF REACH OF CHILDREN

    keep out of reach of children

  • INDICATIONS & USAGE

    indications and uses

  • ACTIVE INGREDIENT

    active ingredients

  • INGREDIENTS AND APPEARANCE
    EXTRA STRENGTH AFTERTAT 
    lidocaine hcl cream
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:69804-003
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    LIDOCAINE HYDROCHLORIDE (UNII: V13007Z41A) (LIDOCAINE - UNII:98PI200987) LIDOCAINE HYDROCHLORIDE ANHYDROUS20 mg  in 1000 mg
    Inactive Ingredients
    Ingredient NameStrength
    PROPOLIS WAX (UNII: 6Y8XYV2NOF) 25 mg  in 1000 mg
    BEHENTRIMONIUM METHOSULFATE (UNII: 5SHP745C61) 60 mg  in 1000 mg
    ALMOND OIL (UNII: 66YXD4DKO9) 25 mg  in 1000 mg
    EUCALYPTUS OIL (UNII: 2R04ONI662) 25 mg  in 1000 mg
    MANGO SEED OIL (UNII: K8LOR30915) 25 mg  in 1000 mg
    NUTMEG OIL (UNII: Z1CLM48948) 5 mg  in 1000 mg
    ALOE VERA LEAF (UNII: ZY81Z83H0X) 40 mg  in 1000 mg
    ROSA CANINA FLOWER OIL (UNII: DUY7M48I1T) 25 mg  in 1000 mg
    COCONUT OIL (UNII: Q9L0O73W7L) 75 mg  in 1000 mg
    COCOA BUTTER (UNII: 512OYT1CRR) 25 mg  in 1000 mg
    WITCH HAZEL (UNII: 101I4J0U34) 600 mg  in 1000 mg
    MORINGA OLEIFERA SEED OIL (UNII: REM6A5QMC0) 25 mg  in 1000 mg
    WALNUT OIL (UNII: Y0P3555R51) 25 mg  in 1000 mg
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:69804-003-0256700 mg in 1 JAR; Type 0: Not a Combination Product
    2NDC:69804-003-03113400 mg in 1 JAR; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph not finalpart34809/07/2015
    Labeler - Ridge Properties (029478762)
    Establishment
    NameAddressID/FEIBusiness Operations
    Ridge Properties029478762manufacture(69804-003)

Related Drugs